MODB | ZFIN | Morpholino Index | Advance Search | BLAST Search | About MODB
Search By For Use * as a wildcard character (e.g. "BMP*"). For Tips on search see Search FAQs.
Morpholino Summary
General Information
Morpholino name: SP3035    
Morpholino sequence: GTTATAATTCCGCAATCCATGTCTG
Find in Genbank
Target name: zgc:100919
Target sequence: (Morpholino Target and ATG)
Search in Genbank Search in Ensembl
CTCGGCCGTATTTCCGCACATGGACAGAGCAGCGCGGATGAATGATGTGTGCGGTATTTAGGACCTGGGGGGAGTTCCCGCAATGCGAGTATGAGAAAGCATGTGACAAACTACTGATCTATAAAGAACACGAGGGAAAAGAAAGCGTCCCAAACAGTTGGAAACATTTCATCGCTTCATCGACCACCATCTTTCAGCAGCAGACATGGATTGCGGAATTATAACATCAAAAACCATTCTTTTGTTACTCAGTTTAATATTTTGGGCTGCTGGAGCGGCCCTCGCATATGTGGGCTCCTATGTGATCAAGAGCTACAACAACTTTGAGGACTTCATGTCTGACAGACACACCCTCATCCCAGCCGCCATCATCATTGGTGTAGCGGTGGTCATGTTCATCATTGGGTTCGTCGGCTGCTGTGCAACCCTGAGAGAATCGAAAGTTGGTTTAGGCCTTTTTCTTATCATCATCATGCTAATCTTCGCAGCTGAAGTCACCGCTTTTGTGTTCGGCATCATCTACAGGGGCAGAATTAGGGGTGACCTAGAAAAGTCAATGAATGACGTCTTCCTGAAGTATGATGGTCTGAACAGTGAAACTCATGCAGTGGATTACTTGCAGTCTCAGCTGGAGTGCTGTGGTGTGAAAAACCAGACCGACTGGACTTTAACATCGTGGTTTGCCCAACATAACAACACTGTCCCTCAATCCTGCTGTAAAGCAAACATGACGCAGTGCACTGGTCAGCTCTCCCAGCCAGATCTGCTGAACACACAGGGGTGTGAAGCTAAACTGGAGCAGGTGCTTCAAGATGTGCTCAGCTATGCAATGCTGGTCATCCTGGGTTTTGCTATCATAAAGTTTTTTGGGATGCTCAGCGTCTGCGTGATCACCTGCAAGAGCAAGAAGAACGAGTATCAACCTCTGTACGCATGATCAGAGTCTCCTGAATCCATCTTTTTCTCTGTTCAGAGAATCTCTACATTCTCTATACTGTGCAGCTAAACACAGCCTCACTGGCACCATCGACAACAGTGCTGACACACACACACACTCAGTTACTTTTATTGCCGTTTGCTTTGAATGCCAAAGCACAAGCTGAAGTGTTTGGTCTGAAATACTGAGCATTATTAGATTAGAAAGAGGGCTGAAAACTATGTTGTTCTTTGATGGTTGATGTTTTTCTGCCAGATAAATACCAAATACTGTATTTATATTTACTGCACAAGGTTTTAGGAAATGTTACTACAGCGGCGTTTCACCAAATATTTCAAATGTATAGGTCAAACCTCAAAGTTGAAAAATGTTTTAAGGATTTTACGTGTTTGTGGGTATTTGTTTTTTCCTTACTGCTGCTGTCTACATGATTTCTGTCTTACTGTTGTCTGTTTATTATATTACATAAAATGGTTCAAACAGAAGGATATTAAATTATAGAAATAAATTGCTCTGAGCG
Gene targeted:
zgc:100919
Find in ZFIN Find in Pubmed
All the morpholinos targets to the gene
Synonyms:
Comments:
Reference:

Survival Curve: Normality Curve:
Note: When more than one data point existed per dose an average was used. p53 morpholino co-injections were used to minimize non-specific toxicity effects (Robu et al. PLoS Genetics 2007)
Screens Performed (number of tests): Defects Observed:
Pigment: (7)
Kidney: (3)
Eye: (3)
Vasculature: (5)
- eye dysplastic
(10%, dose:4.5ng, p53:6.75ng, days: -)
- eye small size
(10%, dose:4.5ng, p53:6.75ng, days: -)
- tail coiled
(10%, dose:4.5ng, p53:6.75ng, days: -)
- cardiovascular system [propose absent flow]
(28.57%, dose:6ng, p53:9ng, days: -)
- notochord undulate
(10%, dose:6ng, p53:9ng, days: -)
- common cardinal vein [proposed pooling]
(21.43%, dose:6ng, p53:9ng, days: -)
- tail coiled
(25.93%, dose:6ng, p53:9ng, days: -)

Images